Results 101 to 110 of about 10,351 (214)

Shigellosis: (Week 06) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 10, 2024

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Shigellosis cases.

core  

Clinical outcomes of carbapenem vs. non-carbapenem therapy in hospitalized adults with shigellosis. [PDF]

Antimicrob Steward Healthc Epidemiol
Zhang Z, Tallman GB, Kendall B, Fox E.
europepmc   +1 more source

Shigellosis: (Week 08) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 24, 2024

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Shigellosis cases.

core  

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial. [PDF]

Lancet Infect Dis
Rouphael N, Baqar S, Dickey M, Quigley C, Pham T, Adams J, Kwatra G, Bechnak S, Smith V, Scherer EM, Graciaa DS, El-Khorazaty J, Fraser JA, Heard S, Cato K, Mejia-Galvis J, Barnoy S, Chandrasekharan L, Porter CK, Suvarnapunya AE, Venkatesan MM, Frenck RW, DMID 17-0112 Study Group.   +22 more
europepmc   +1 more source

Shigellosis: (Week 03) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending January 20, 2024

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Shigellosis cases.

core  

Genomic epidemiology and antimicrobial resistance profile of <i>Shigella</i> isolated from diarrhoea diseases in under-five children in Blantyre, Malawi. [PDF]

Microb Genom
Sibande GT, Chong CE, Kiran A, Kutambe B, Charles M, Maiden V, Baker KS, Cornick J.   +7 more
europepmc   +1 more source

Shigellosis: (Week 17) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 20, 2024

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Shigellosis cases.

core  

<i>Shigella</i> infections in the era of antimicrobial resistance: Insights into cephalosporin use. [PDF]

New Microbes New Infect
Wang W, Qin Y, Wang Y, Li X, Kuang D, Rajaofera MJN.   +5 more
europepmc   +1 more source

Shigellosis: (Week 35) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 31, 2024

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Shigellosis cases.

core  

Fecal biomarkers to characterize intestinal inflammation among children with medically attended diarrhea across six low-resource settings: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study. [PDF]

PLoS Negl Trop Dis
Horne B, Otieno Onyando B, Badji H, Mujahid W, Bhuiyan TR, Bakali M, Iqbal J, Olortegui MP, Pavlinac P, Ceesay BE, Schultes O, Tennant SM, Ogwel B, Witte D, Atlas H, Ahmed N, Ochieng JB, Sears K, Islam S, Saidi Q, Jallow SJ, Hussain Z, Garcia Bardales P, Platts-Mills JA, Omore R, Khanam F, Mosharraf MP, Secka O, Munthali V, Kosek MN, Ndalama M, Cornick J, Yousafzai MT, Hossain MJ, Sonye C, Qadri F, Rogawski McQuade ET, Brennhofer SA.   +37 more
europepmc   +1 more source